Diagnosing diseases is basically the frontlines when it comes to fighting against illnesses and how effectively and efficiently this is done will affect how the rest of the battle goes. Unfortunately, diagnosis can be expensive, depending on the disease. Thanks to a new microchip, which can cost only $0.1 to create, this might not be a problem anymore.
The microchip in question was created by a team of engineers from Stanford who published their findings in the Proceedings of the National Academy of Sciences. Not only is the chip tiny, it’s also incredibly inexpensive to produce and can be manufactured at a large scale in a very short period of time.
“For the developing world, point-of-care (POC) diagnostics design must account for limited funds, modest public health infrastructure, and low power availability,” the paper reads. “To address these challenges, here we integrate microfluidics, electronics, and inkjet printing to build an ultra–low-cost, rapid, and miniaturized lab-on-a-chip (LOC) platform.”
Calling it the FNIP chip, the researchers created the device with three layers of varying expendability. As for how it is used, it’s basically a two-step process. First, the user would need to customize the configuration in order to suit the particular disease that needs to be diagnosed, Futurism reports. Next, the necessary samples for analysis can then be printed onto the top layer of the chip.
So, which diseases can this microchip detect? So far, the researchers tested it to analyze cancer fluid and succeeded. They also used it to diagnose immune cells and was able to pull off similar results as another diagnostic tool that would have cost $100,000 in comparison.
Before anyone gets too excited, however, the researchers are saying that it would take some time before the microchip becomes widely available. There are some hurdles to overcome first, including more tests to see if the platform is even safe to use.


U.S. Issues Cuba Health Alert as Illnesses Rise
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Tencent Launches TenPayGo Payment App for Foreign Tourists in China
3 clinical-grade skincare creams you really shouldn’t buy online
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Meta Connect Spotlights Camera-Free Smart Glasses Amid Privacy Concerns
OpenAI Agent Breaches Australia Medicare Data Portal
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
New Mexico Measles Outbreak Cost Reached $5.4 Million, Study Finds
Former OpenAI Data Center Chief Chris Malone Joins Nvidia
Xi Calls for Deeper U.S.-China AI Cooperation in Trump Talks
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
GLP-1 Weight-Loss Drug Use Surges Among U.S. Children
Oracle Shares Fall as New Mexico AI Data Center Faces Power Delays 



